Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
Small nerve damage can be reversible if detected early!
The non-invasive medical device SUDOSCAN is a highly sensitive and reproducible tool for the early detection of peripheral neuropathy. Early detecting and follow-up of peripheral neuropathy could help monitor disease progression and assess treatment efficacy to improve patient management and control complications caused by diseases like diabetes.
*Schwarz PE, Brunswick P, Calvet JH. EZSCAN a new tool to detect diabetes risk. Br J Diabetes Vasc Dis 11:204-209.
WHY SUDOSCAN IS CHOSEN BY PHYSICIANS ?
Learn why Physicians use SUDOSCAN during the diagnostic evaluation of Small Fiber and Autonomic Neuropathy for the early detection of potentially treatable diseases. Discover why your patients will appreciate a non-invasive test to monitor their disease and treatment outcome.
SUDOSCAN featured on the Discovery Channel Show – Innovations Series
Impeto Medical on Worldwide Business with Kathy Ireland